Search results for " Mesoporous silica nanoparticles"

showing 3 items of 3 documents

Formulation of Mesoporous Silica Nanoparticles for Controlled Release of Antimicrobials for Stone Preventive Conservation

2020

The biotic deterioration of artifacts of archaeological and artistic interest mostly relies on the action of microorganisms capable of thriving under the most disparate environmental conditions. Thus, to attenuate biodeterioration phenomena, biocides can be used by the restorers to prevent or slow down the microbial growth. However, several factors such as biocide half-life, its wash-out because of environmental conditions, and its limited time of action make necessary its application repeatedly, leading to negative economic implications. Sound and successful treatments are represented by controlled release systems (CRSs) based on porous materials. Here, we report on the design and developm…

Biocidecondensation in emulsionNanoparticle02 engineering and technologyBacterial growth010402 general chemistrySettore BIO/19 - Microbiologia Generale01 natural sciencesKocuria rhizophilabiocideslcsh:Chemistrystone conservationSpecific surface areabiodeteriorationmesoporous silica nanoparticlesOriginal ResearchSettore CHIM/02 - Chimica Fisicacontrolled release systemsbiologyChemistryGeneral Chemistrycultural heritageMesoporous silica021001 nanoscience & nanotechnologybiology.organism_classificationControlled release0104 chemical sciencesChemistryChemical engineeringbiocides biodeterioration condensation in emulsion controlled release systems cultural heritage mesoporous silica nanoparticles stone conservationlcsh:QD1-999Emulsion0210 nano-technologyFrontiers in Chemistry
researchProduct

New biocides based on imidazolinium-functionalised hybrid mesoporous silica nanoparticles

2022

Here, we report the development of a new biocide based on hybrid mesoporous silica nanoparticles (MSN). The MSN was synthesized by condensation method in emulsion followed by grafting with two different silylated ionic liquid moieties, namely butyl imidazolinium bromide and imidazolinium propansulfonate betaine. Features of nanoparticles were characterized by Thermogravimetry, Infrared and ss-NMR Spectroscopy, and Transmission Electron Microscopy. The antibacterial properties were tested against a Gram-positive bacterial strain previously isolated from artefacts of interest in the field of Cultural Heritage. Interestingly, the hybrid material presents an antibacterial activity higher than i…

Biocides Mesoporous silica nanoparticles Ionic liquids Biodeterioration Stone conservation Preventive conservationMechanics of MaterialsGeneral Materials ScienceGeneral ChemistryCondensed Matter Physics
researchProduct

Nanosensor for Sensitive Detection of the New Psychedelic Drug 25I-NBOMe.

2020

[EN] This work reports the synthesis, characterization, and sensing behavior of a hybrid nanodevice for the detection of the potent abuse drug 25I-NBOMe. The system is based on mesoporous silica nanoparticles, loaded with a fluorescent dye, functionalized with a serotonin derivative and capped with the 5-HT2A receptor antibody. In the presence of 25I-NBOMe the capping antibody is displaced, leading to pore opening and rhodamine B release. This delivery was ascribed to 5-HT2A receptor antibody detachment from the surface due to its stronger coordination with 25I-NBOMe present in the solution. The prepared nanodevice allowed the sensitive (limit of detection of 0.6 mm) and selective recogniti…

SerotoninMesoporous silica nanoparticles25I-NBOMehallucinogenic drugsMescalinesensorsCatalysischemistry.chemical_compoundAgonist 5-HT2A serotonin receptorQUIMICA ORGANICAQUIMICA ANALITICAmedicineRhodamine BHumansmesoporous silica nanoparticlesNanodeviceLysergic acid diethylamideDetection limitSensorsQUIMICA INORGANICAOrganic ChemistryMDMAGeneral ChemistryMesoporous silicaHallucinogenic drugs25I-NBOMeCombinatorial chemistrychemistryDimethoxyphenylethylamine25I-NBOMe agonist 5-HT2A serotonin receptor hallucinogenic drugs mesoporous silica nanoparticles sensorsHallucinogensagonist 5-HT2A serotonin receptormedicine.drug
researchProduct